A 39-year-old nulligravid woman presents to the clinic complaining of highly unpredictable… — USMLE Step 2 CK

A $39$ -year-old nulligravid woman presents to the clinic complaining of highly unpredictable and heavy menstrual bleeding for the past $8$ months. She states that her menstrual cycles vary from $20$ to $65$ days in length, with bleeding often lasting up to $14$ days and requiring her to use double protection with both a tampon and a thick pad. She has a medical history significant for type $2$ diabetes mellitus and hypertension. Current medications include metformin and lisinopril. Her body mass index is $38 \text{ kg/m}^2$ . Blood pressure is $138/86 \text{ mmHg}$ . A urine pregnancy test obtained in the clinic is negative. Pelvic examination reveals normal external genitalia, a visually normal cervix, and a normal-sized, non-tender, mobile uterus. Which of the following is the most appropriate next step in the management of this patient?

Endometrial biopsyAnswer
B
Transvaginal ultrasonography
C
Cyclic progestin therapy
D
Insertion of a levonorgestrel-releasing intrauterine device
E
Measurement of serum follicle-stimulating hormone and luteinizing hormone

Answer

Endometrial biopsy

The most appropriate next step in the management of this patient is an endometrial biopsy. Although she is premenopausal and under the age of

45

, she has significant risk factors for endometrial cancer due to chronic unopposed estrogen exposure. Her marked obesity (BMI of

38 \text{ kg/m}^2

) and long history of unpredictable menses strongly suggest chronic anovulation. Adipose tissue contains aromatase, which peripherally converts androgens into estrone. In the absence of regular ovulation, no corpus luteum is formed, meaning no progesterone is produced to stabilize the uterine lining. This continuous, unopposed estrogen stimulation leads to endometrial proliferation, increasing the risk of atypical hyperplasia and endometrial adenocarcinoma. Current guidelines recommend endometrial biopsy for all women

\ge 45

years with abnormal uterine bleeding, AND for women

< 45

years if they have risk factors such as obesity, chronic anovulation, nulliparity, or failed medical management. A tissue diagnosis is essential prior to initiating any treatment.

Step-by-Step Solution

Evaluate the patient's age and presenting symptoms.

The patient is a 39-year-old premenopausal woman presenting with abnormal, heavy, and unpredictable uterine bleeding.

Abnormal uterine bleeding (AUB) algorithms differ significantly based on the patient's age and menopausal status.

Identify specific risk factors for endometrial cancer.

The patient has a BMI of 38 kg/m^2, type 2 diabetes, nulliparity, and a history of unpredictable menses indicative of chronic anovulation.

Obesity and chronic anovulation result in peripheral conversion of androgens to estrone and an absence of luteal phase progesterone, creating a state of chronic, unopposed estrogen exposure.

Determine the indication for endometrial sampling.

Guidelines dictate that women under 45 years of age with AUB and significant risk factors for unopposed estrogen exposure must undergo endometrial biopsy.

To rule out endometrial hyperplasia or endometrial adenocarcinoma before initiating any medical or surgical treatment.

Key Concept

Premenopausal women younger than 45 years with abnormal uterine bleeding require an endometrial biopsy to rule out malignancy if they possess high-risk factors for unopposed estrogen exposure, such as obesity, chronic anovulation, or nulliparity.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic